Abstract-Recently, 4'C-ethynyl nucleoside analogues have been identified as highly potent agents against HIV-l , including several multidrug-resistant strains. In contrast to most known nucleoside inhibitors 4'C-ethynyl nucleoside analogues possess a 3'-hydroxyl function . Here we show that the 5' O-triphosphate of 4' C-ethynyl thymidine gets readily incorporated into a nascent DNA strand by HIV-l reverse transcriptase and significantly inhibits further post-incorporation chain extension by the enzyme.
Most known nucleoside reverse transcriptase inhibitors (NR TI) like 3' C-azido-3'-deoxythymidine (AZT) are first phosphorylated by cellular kinases to yield the respective 5' O-triphosphates. These activated nucleotides bind competitively to the HIV -1 reverse transcriptase active site and cause chain termination after incorporation into the nascent DNA strand due to a lack of a 3'-hydroxyl function.! Recently, 4' C-ethynyl nucleoside analogues have been identified as potent agents against HIV -1, including several multidrug-resistant strains. 2 -5 Particularly, this new class of NRTI exhibits potent activity against several multidrug-resistant (MDR) HIV -1 strains that represent a severe restriction to therapy. In contrast to common NRTls, 4'C-ethynyl nucleoside analogues possess a 3'-hydroxyl group. However, the exact mode of action of these analogues is still unclear. It has been speculated that the mechanism of inhibition of HIV-l reverse transcriptase (RT) is similar to that of AZT.5 Thus, 5'O-triphosphate analogues generated by cellular kinases are thought to get incorporated into a nascent DNA strand by HIV-I RT, which in turn results in termination of further chain extension despite the presence of a free 3'-hydroxyl group. However, hitherto no studies with a respective 4' C-ethynyl nucleoside-5' O-triphosphate have been described that indeed show such kind of mechanism of action. Thus, we set out to synthesize a 4' C-ethynyl nucleoside-5' O-triphosphate in order to evaluate its First we synthesized 4'C-ethynyl thymidine 1 following a described route. 2 1 was subsequently converted to the respective 5'O-triphosphate 2 (Scheme 1) using a multi step one-pot reaction sequence. 6 To evaluate the potential of 2 to act as an inhibitor of HIV-l RT promoted DNA synthesis we used an assay format recently developed to measure DNA polymerase activity in real time. 7 In this assay format a fluorescence increase is generated by HIV-I RT promoted DNA synthesis that results in opening of a template containing a molecular beacon construct. By time-resolved observation of fluorescence increase, reaction velocities can be deduced . When testing 2 we observed decreasing activity with increasing concentrations of the analogue. The results obtained for 2 were compared to those derived from known HIV-I RT inhibitors that is AZT TP and nevirapine (Fig. I) . To gain insights into the mechanism of action of 2 on HIV-I RT we performed primer extension reactions using a radioactively labeled primer strand, subsequent analysis by high-resolution denaturating PAGE and autoradiography. We designed a primer template complex in a way that after extension of the primer strand by four nucleotides a single dA-moiety in the template at position 25 calls for incorporation of a thymidine analogue by HIV -I R T ( Fig. 2A) . In a first set of experiments we performed primer extension reactions using dATP, dCTP, dGTP, and 2 at varied concentrations. For comparison we performed reactions under the same conditions using AZT TP instead of 2 (Fig. 2B ). When neither 2 nor AZT TP were present the reactions arrest after yielding a 24nt long reaction product due to the absence of any thymidine analogue (Fig. 2B, lanes I ). With increasing amounts of 2 or AZT TP 25nt long reaction products were detected (Fig. 2B, lanes 2-6) . However, no further reaction occurs after incorporation of a 4' C-ethynyl thymidine under the applied condition. This is in particular interesting since a free 3'-hydroxyl function at the 3'-primer terminus is present that in principle should be available for further chain extension. Nevertheless, further chain extension is blocked by addition of a 4' C-ethynyl group in comparison to an unmodified DNA primer strand. Thus, the chain terminating action of 2 on HIV-I RT catalyzed DNA synthesis resembles the action of AZT TP, even both molecules differ in respect to the presence of a free 3'-hydroxyl group.
These results are similar to those obtained with other known 4' C-modified nucleoside-5' O-triphosphates. 4' C-azido-, 8 4' C-acyl-, l),l Q and 4' C-alkyl-thymidine-5' O-triphosphates [11] [12] [13] have been shown to exert strong blockage of post-incorporation chain extension by various DNA polymerases including HIV-I RT. This feature is presumably caused through unfavorable interaction of the added 4' C-group with functionally important HIV-I RT motifs such as the so called 'primer grip', which contacts the primer 3'-terminus. 14 .. 16 Thus, presence of the additional bulk hampers the formation of productive enzyme substrate complexes resulting in blockage of further chain extension.
Next, we investigated whether 2 is able to compete with incorporation with unmodified TTP by HIV-I RT. As seen above, incorporation of a 4' C-ethynyl thymidine moiety blocks further HIV-I RT promoted DNA synthesis. Thus, incorporation of 2 in the presence of natural TTP should result in the accumulation of 25nt long reaction products if 2 is indeed a substrate for the enzyme under these conditions. In the absence of any thymidine analogue 2 or AZT TP and in the presence of TIP full length reaction product formation was observed (Fig. 3, lanes I ).
With increasing amounts of 2 accumulation of a 25nt long reaction product was observed accompanied by a decreasing amount of reaction products longer than 25nt (Fig. 3, lanes 2 extension by HIV-l RT and leads to post-incorporation chain termination.
Our experiments unambiguously show for the first time that the 5'O-triphosphate of 4'C-ethynyl thymidine 1, a member of a family of promising antiviral nucleoside derivatives, is an inhibitor of HIV-l RT catalyzed DNA synthesis and gets readily incorporated by the enzyme into a growing DNA strand. Interestingly, after incorporation of a 4'C-ethynyl thymidine moiety DNA synthesis promoted by HIV-l RT arrests despite the presence of a free 3'-hydroxyl group at the primer terminus, which in principle should allow proceeding DNA synthesis. Furthermore, our experiments indicate that 2 can compete with TTP as a substrate for HIV-l RT since 2 gets readily incorporated into a growing DNA strand even in the presence of unmodified TTP.
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